【Whitehead Biotech Pharmaceutical Co., Ltd.】2026 Q1 EPS TWD -0.08
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Whitehead Biotech Pharmaceutical Co., Ltd. announced its first-quarter financial results for 2026, reporting a basic EPS of TWD -0.08, operating revenue of TWD 35 million, and after-tax net loss of TWD 27 million. These figures reflect the company's financial performance in the biotechnology and medical industry.